Status:

COMPLETED

Food Effect Study of HSK47388 in Healthy Subjects

Lead Sponsor:

Haisco Pharmaceutical Group Co., Ltd.

Conditions:

Pharmaceutical Preparations

Health Adult Subjects

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

This is a Phase 1, open-label, randomized, three-period crossover trial study to evaluate the effect of food and dosing and meal timing intervals on the pharmacokinetics (PK) of HSK46575 in healthy ad...

Detailed Description

The study consists of 3 treatment sequences in a 3-period, crossover design. Approximately 15 healthy adult participants will be randomized 1:1:1 to one of the following sequences: Sequence A: Partic...

Eligibility Criteria

Inclusion

  • Must have given written informed consent before any study-related activities are carried out and must be able to understand the full nature and purpose of the study, including possible risks and adverse effects.
  • Adult males and females between ≥ 18 and ≤ 55 years (inclusive) at Screening.
  • Able and willing to attend the necessary visits to the study site

Exclusion

  • Participants with any disease history that may affect the safety evaluation or in vivo process of IP as judged by the PI or delegate, including central nervous, cardiovascular, digestive, respiratory, urinary, blood, immune and endocrine diseases. Participants with childhood asthma (resolved) can be included at the discretion of the PI.
  • Underlying physical or psychological medical condition that, in the opinion of the PI or delegate, would make the participant unlikely to comply with the protocol or complete the study per protocol.
  • Participants who may not be able to complete the study for other reasons, cannot comply with the requirements of the study, or are unsuitable to participate in the study as judged by the PI or delegate.

Key Trial Info

Start Date :

August 8 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 28 2025

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT07192692

Start Date

August 8 2025

End Date

August 28 2025

Last Update

September 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Sixth People's Hospital of Zhengzhou

Zhengzhou, Henan, China